Christoph Mundhenke
Arzt,
Hochschullehrer
Geboren:
1970
Hat mitgewirkt an:
-
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
-
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells
-
Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial
-
Malignant melanoma of the urethra: a rare histologic subdivision of vulvar cancer with a poor prognosis